In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor. Subscribe to our ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

A new study from Memorial Sloan Kettering Cancer Center finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The ...

When we think of the immune system, we usually picture it fighting off colds and the flu. But what if it could also help fight cancer? A new study suggests that's exactly what's happening specifically ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of cancer-related death worldwide. One critical factor that makes treating colon ...

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...

The findings are particularly relevant for India, where colorectal cancer is emerging as a growing public health concern ...